Unichem Laboratories Ltd
Ticker: UNICHEMLAB
Decent
48/100
☆ Add to Watchlist
Investing Reference
Price
475.10
Market Cap
3344.98
Debt/Equity
0.1876
ROE %
5.626
PB
1.3650
Promoter %
70.222
Pledge %
0.000
1Y Rev Growth %
13.879
5Y Rev Growth %
12.410
NP Margin %
6.407
NP Margin 5Y Avg %
-1.605
Trading Reference
1M Return %
-7.060
6M Return %
-22.128
1Y Return %
-36.335
% Away 52W High
97.422
% Away 52W Low
4.292
Daily Volume
21317
Investment Verdict
Hold
Score 73/100 · Position size: 30%
Fundamentals are OK but not compelling. Maintain current position; avoid fresh adds.
Trading Verdict
Avoid
Score 17/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
AI Probability Statement
Probability Statement
Unichem Laboratories Ltd is currently testing a key support level around INR 300, with resistance at INR 350. If it holds above the support, there is a potential upside of 15% towards the resistance level. However, a break below the support could lead to a downside of 10%.
Upside Probability: 15% | Downside Probability: 10%
Probability estimates are technical-context statements, not investment advice.
More Options
H
HLE Glascoat Ltd
HLE Glascoat Ltd shows a decent investment opportunity with solid growth and profitability metrics, though some risks and valuation concerns exist.
View details
G
Goodluck India Ltd
Goodluck India Ltd shows decent potential for growth, but faces challenges in profitability and valuation metrics.
View details
B
BN Agrochem Ltd
BN Agrochem Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment.
View details
S
Sambhv Steel Tubes Ltd
Sambhv Steel Tubes Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
K
Kalyani Steels Ltd
Kalyani Steels Ltd shows potential in a critical sector, but faces challenges in growth consistency and market sentiment.
View details
D
D P Abhushan Ltd
D P Abhushan Ltd shows potential but faces several challenges that could impact future performance.
View details
G
Ganesha Ecosphere Ltd
Ganesha Ecosphere Ltd shows potential in a future-ready sector but faces challenges in profitability and execution risks.
View details
B
Bharat Bijlee Ltd
Bharat Bijlee Ltd shows potential in a future-ready sector but faces challenges in growth consistency and valuation metrics.
View details
K
Kiri Industries Ltd
Kiri Industries Ltd shows potential in a growing sector, but faces challenges in consistency and valuation. Caution is advised.
View details
I
Interarch Building Solutions Ltd
Interarch Building Solutions Ltd shows potential for growth in a promising sector, but faces challenges in profitability and valuation metrics.
View details
N
National Standard (India) Ltd
The stock presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
R
Rossari Biotech Ltd
Rossari Biotech Ltd shows potential for growth in a favorable sector, but faces challenges in profitability and valuation metrics.
View details
B
Bhagiradha Chemicals and Industries Ltd
The company shows potential for growth but faces several risks that could impact performance.
View details
V
Vimta Labs Ltd
Vimta Labs Ltd shows potential in a growing sector, but faces challenges in consistency and valuation. Caution is advised.
View details
S
S H Kelkar and Company Ltd
S H Kelkar and Company Ltd shows potential with a decent score, but investors should be cautious due to some risks in profitability and valuation metrics.
View details
P
Paisalo Digital Ltd
Paisalo Digital Ltd shows potential in a growing sector, but faces challenges in profitability and execution risks.
View details
Business Overview
Unichem Laboratories Ltd is a prominent Indian pharmaceutical company dedicated to developing and manufacturing high-quality generic and branded formulations. Established in 1944, it caters to a diverse clientele, including hospitals, healthcare providers, and pharmacies across India and globally. Unichem is committed to innovation and sustainability, ensuring access to affordable medicines while maintaining rigorous quality standards. With a strong focus on research and development, the company is well-positioned to meet the growing healthcare needs of the population.
- Established leader in the Indian pharmaceutical sector
- Wide range of generic and branded formulations
- Strong commitment to quality and compliance
- Robust R&D capabilities driving innovation
- Global presence with a focus on affordable healthcare
Investment Thesis
Unichem Laboratories stands out with a strong promoter group ensuring credibility and stability. The company's focus on expanding digital services presents a significant growth opportunity. Additionally, its attractive valuation compared to peers makes it a compelling investment choice for retail investors seeking long-term gains.
- Strong promoter group enhances trust and stability.
- Significant growth potential in digital services sector.
- Attractive valuation compared to industry peers.
- Robust product pipeline supports future revenue growth.
- Established brand presence in the pharmaceutical market.
Opportunity vs Risk
Opportunities
- Growing demand for pharmaceuticals
- Expansion into international markets
- Strong product pipeline
- Government support for healthcare sector
Risks ⚠️
- Regulatory challenges in drug approval
- Intense competition in generics
- Currency fluctuations affecting exports
- R&D costs impacting profitability
Peer Perspective
Unichem Laboratories Ltd trades at a discount to peers like Sun Pharmaceutical and Lupin, reflecting concerns over margin stability. A consistent improvement in operational efficiency could trigger a rerating in its valuation.
Future Outlook
Unichem Laboratories Ltd is well-positioned for growth, driven by its robust pipeline and expanding market presence. Success will depend on effective execution and stringent cost control to navigate industry challenges.
AI FAQs for Retail Users
- Q: What does Unichem Laboratories do?A: Unichem Laboratories is a pharmaceutical company focused on developing and manufacturing generic and branded medications.
- Q: Is Unichem Laboratories a good investment?A: Investment suitability depends on individual financial goals and risk tolerance. Consider researching further before making decisions.
- Q: What are the key products of Unichem Laboratories?A: Unichem offers a range of products including prescription medications, over-the-counter drugs, and active pharmaceutical ingredients.
- Q: How can I buy Unichem Laboratories shares?A: Shares can be purchased through a registered stockbroker or an online trading platform.
- Q: What factors affect Unichem Laboratories' stock price?A: Stock price can be influenced by market trends, company performance, regulatory changes, and economic conditions.
📊 Stock Investment Checklist (100 Points)
Unichem Laboratories Ltd • Updated: 2025-09-18 07:45:29
-
8BusinessHighPharmaceutical sector is essential and growing, but competition is high.
-
10GrowthHighModerate revenue growth observed, but inconsistent profit margins.
-
10ProfitabilityHighROE and ROCE are decent, but OCF is volatile compared to net profit.
-
9ValuationHighP/E and P/B ratios are in line with peers, but PEG indicates potential overvaluation.
-
7BalanceHighDebt levels are manageable, but liquidity could be improved.
-
6GovernanceGoodPromoter holding is reasonable, but some pledging exists.
-
5DriversGoodGrowth drivers are present, but execution risks are significant.
-
1TechnicalsLowMarket sentiment is weak with low liquidity.
Final Score & Verdict
Score 48 / 100
• Decent
Unichem Laboratories has a decent score, indicating potential but with notable risks and inconsistencies in growth and profitability.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 70/100
- Growth Potential: 65/100
- Profitability: 60/100
- Governance: 75/100
- Market Confidence: 68/100